SCHEMBL8286184

SCHEMBL8286184

O=C(CNc1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12)N1CCCCC1

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 1/20 0.39
CHRM2 P08172 1/20 0.38
CHRM4 P08173 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
GRM5 P41594 1/20 0.38
PTGS2 P35354 1/20 0.37
MALT1 Q9UDY8 1/20 0.36
MAPT P10636 2/20 0.36
GAA P10253 1/20 0.36
RAB9A P51151 1/20 0.35
PRMT3 O60678 3/20 0.35
ACHE P22303 1/20 0.35
TP53 P04637 2/20 0.34
POLB P06746 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8286178 0.86 GAA (0.36) ALDH1A1MAPTGAARAB9A
SCHEMBL8286211 0.84 MAP3K8 (0.34) MAPTGAA
SCHEMBL8286557 0.83 NPC1 (0.40) ALDH1A1KMT2AGRM5MAPTGAA
SCHEMBL8286173 0.83 GAA (0.36) ALDH1A1KMT2AMAPTGAARAB9A
SCHEMBL8287258 0.83 GRM5 (0.45) ALDH1A1KMT2ACHRM2CHRM4CHRM1
SCHEMBL8286182 0.82 MAT2A (0.46) ALDH1A1GAA
SCHEMBL8286432 0.81 KMT2A (0.39) ALDH1A1KMT2ACHRM2CHRM4CHRM1
SCHEMBL8287246 0.81 GAA (0.39) ALDH1A1KMT2APTGS2MAPTGAA
SCHEMBL8287276 0.80 MAT2A (0.40) MAPTGAARAB9A
SCHEMBL8286174 0.79 BRAF (0.39) ALDH1A1KMT2AMAPTGAARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed